Table 3 Relation of headache to clinical and laboratory data

Age

28.5 ± 7.9

31.2 ± 9.8

32.3 ± 7.5

29.8 ± 10.4

0.7

0.5

Age of onset

26.2 ± 8.4

27.4 ± 9.7

30.5 ± 6.3

27.0 ± 9.7

0.4

0.7

Duration of disease

2.5 ± 2.2

3.2 ± 2.7

1.9 ± 1.8

2.8 ± 0.9

0.6

0.5

Haemoglobin

9.6 ± 1.1

10.1 ± 0.8

10.01 ± 0.9

10.01 ± 0.6

1.1

0.3

WBCs

4.9 ± 1.8

4.1 ± 1.1

5.1 ± 0.4

5.1 ± 1.4

1.4

0.2

Platelets

206.8 ± 104.2

225.1 ± 111.1

214.9 ± 138.3

182.1 ± 70.9

0.1

0.9

Creatinine

1.1 ± 0.9

1.2 ± 0.8

1.2 ± 0.7

0.7 ± 0.1

0.6

0.5

Proteinuria

1.8 ± 2.7

1.6 ± 2.1

3.3 ± 1.2

0.72 ± 0.19

1.1

0.3

SLEDAI

5.6 ± 5.7

7.2 ± 6

8.6 ± 3.1

4.0 ± 4.0

0.9

0.4

VAS

4.17 ± 1.1

4.8 ± 1.5

5.3 ± 2.1

4.2 ± 1.4

2.2

0.09

n

%

n

n

%

n

%

Male

5

7.7%

4

14.8%

0

0%

1

20%

1.9

0.5

Female

60

92.3%

23

85.2%

3

100%

4

80%

Mucocutaneous

61

93.8%

25

92.5%

2

66.7%

3

60%

8.7

0.04*

Serositis

16

24.6%

10

37.03%

0

0%

0

0%

4.5

0.2

Arthritis

36

55.4%

18

66.7%

1

33.3%

4

80%

2.7

0.4

aPL

11

16.9%

19

70.4%

3

100%

1

20%

19.1

< 0.000٭

ACL

9

13.8%

18

66.6%

3

100%

1

20%

19.1

< 0.000٭